News Sentiment

HLUN-A sentiment intelligence

H. Lundbeck A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 56 Balanced news tone 15 relevant articles
Exchange CPH Denmark
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 36.60 Week of 19 Jun 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 15

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+0.1% over one week, +2.5% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

H. Lundbeck (CPSE:HLUN B) Stock Could Be 10% Undervalued After Asedebart Phase II Data

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 0.1% Price digesting
Trend fit Trend active 2.5% over four weeks
Fair value 17.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 12
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 15
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 3
marketscreener.com 3
Seeking Alpha 2
The Pharma Letter 1
European Biotechnology Magazine 1
Reuters 1
Business Wire 1
MedCity News 1

Event Lens

What the news is about

Classified themes
Market update 9
Earnings 2
Deals and strategy 2
Analyst action 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-15 of 15
marketscreener.com Direct company coverage

H. Lundbeck A/S : Lundbeck

Tone
Neutral 50/100
Event
Market update
Published
20 Nov 2024 08:00
Source
marketscreener.com